This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2029 Remove Disease Remove Pharma Companies Related Topics
Cell Based Assays Molecular Biology Clinical Development Biosimilars Vaccine RNA Clinical Research Pharmaceuticals Therapies Trials More Related Topics >
article thumbnail

The trends driving ELRIG Drug Discovery 2022

Drug Discovery World

OCTOBER 4, 2022

This year’s event will cover some of the most exciting advancements in areas spanning screening, automation, high content imaging, disease models, cell and gene therapies and how innovation is being driven through partnerships and collaborations. This year has seen some major deals announced by big pharma companies.

Drugs 130
Drugs Therapies Clinical Trials Cell Based Assays 130
article thumbnail

What is the largest CRO in the US?

Vial

MARCH 1, 2024

billion by 2029. It ensures regulatory compliance for over 15 long-term post-authorization safety studies across eight disease indications. For the fourth consecutive year, PPD, as Thermo Fisher Scientific’s clinical research business, was recognized as the 2023 PharmaTimes Clinical Research Company of the Year.

Clinical Trials 52
Clinical Trials Clinical Research Laboratories Trials 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024